Severe Steroid-responsive Skin Disorders Related to Ledipasvir and Sofosbuvir for HCV-Reference-Cited by-同舟云学术

Severe Steroid-responsive Skin Disorders Related to Ledipasvir and Sofosbuvir for HCV

Published:2018 Issue:8 Volume:57 Page:1101-1104
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Tadokoro Tomoko¹,Morishita Asahiro¹,Fujita Koji¹,Oura Kyoko¹,Sakamoto Teppei¹,Nomura Takako¹,Tani Joji¹,Yoneyama Hirohito¹,Masaki Tsutomu¹

Affiliation:

1. Department of Gastroenterology and Neurology, Kagawa University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/57/8/57_9744-17/_pdf

Reference11 articles.

1. 1. Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 138: 513-521, 521.e1, 2010.

2. 2. Asselah T, Marcellin P. New direct-acting antivirals' combination for the treatment of chronic hepatitis C. Liver Int 31: 68-77, 2011.

3. 3. Afdhal N, Zeuzem S, Kwo P, et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med 370: 1889-1898, 2014.

4. 4. Mizokami M, Yokosuka O, Takehara T, et al. Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial. Lancet Infect Dis 15: 645-653, 2015.

5. 5. Jacobson IM, McHutchison JG, Dusheiko G, et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 364: 2405-2416, 2011.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety considerations in the management of hepatitis C and HIV co-infection;Expert Opinion on Drug Safety;2023-04-27

2. An adverse skin reaction with probable nonallergic pathogenesis related to glecaprevir/pibrentasvir;International Journal of Dermatology;2019-09-25

3. Palisaded neutrophilic and granulomatous dermatitis associated with ledipasvir/sofosbuvir;JAAD Case Reports;2018-09

4. Ledipasvir/sofosbuvir;Reactions Weekly;2018-05